The FDA has denied Lykos Therapeutics' marketing application for its post-traumatic stress disorder (PTSD) therapy based on MDMA, also known as ecstasy, in a setback for the emerging psychedelic ...

While some studies suggest that 3,4-methyl​enedioxy​methamphetamine (MDMA)-assisted therapy can reduce symptoms (PTSD) in ...

Poulter said the study, compiled by research clinics around the world, clearly demonstrated the benefits of what’s known as MDMA-assisted therapy for PTSD. It involves taking the drug three ...

After the FDA declined to approve Lykos Therapeutics’ MDMA-assisted therapy for post-traumatic stress disorder, companies are ...

A medicine based on MDMA – the active ingredient in recreational drug ecstasy – is on the cusp of FDA approval as a treatment for post-traumatic stress disorder (PTSD), according to the ...

The U.S. Food and Drug Administration (FDA) has issued a complete response letter for MDMA-assisted psychotherapy (MDMA-AT) for treating post-traumatic stress disorder (PTSD) in which it calls for ...

More than 70 percent of the MDMA group no longer qualified for a PTSD diagnosis, compared to 48 percent of the control group. The FDA's advisers worried that the negative effects of MDMA-assisted ...

MDMA-assisted psychotherapy has been shown to be a safe and effective treatment for PTSD and complex trauma. Why did the FDA ...

FDA Rejects MDMA-AT for PTSD, but Lykos Vows to Push On Despite the FDA's rejection of MDMA-assisted therapy, Lykos Therapeutics plans to push ahead for approval, despite internal turmoil and ...

There’s been a lot of news recently about the use of MDMA ... adult-onset PTSD and complex PTSD stemming from prolonged childhood trauma. The bad news? The U.S. Food and Drug Administration ...